BYDENAF Trademark

Trademark Overview

On Tuesday, January 20, 2015, a trademark application was filed for BYDENAF with the United States Patent and Trademark Office. The USPTO has given the BYDENAF trademark a serial number of 86508416. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 24, 2018. This trademark is owned by Raptor Pharmaceuticals Inc.. The BYDENAF trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating genetic disorders; pharmaceutical preparations for treating neurological disorders; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations for treating Huntington's disease and related disorders; pharmaceutical preparations for treating fibrotic disorders; pharmaceutical preparations for treating mitochondrial disease; and pharmaceutical preparations for treating NAFLD and NASH disease and related disorders
bydenaf

General Information

Serial Number86508416
Word MarkBYDENAF
Filing DateTuesday, January 20, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 24, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 23, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating genetic disorders; pharmaceutical preparations for treating neurological disorders; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations for treating Huntington's disease and related disorders; pharmaceutical preparations for treating fibrotic disorders; pharmaceutical preparations for treating mitochondrial disease; and pharmaceutical preparations for treating NAFLD and NASH disease and related disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 31, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHorizon Orphan LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressLAKE FOREST, IL 60045
Party NameRaptor Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNovato, CA 94949
Party NameRaptor Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Trademark Events

Event DateEvent Description
Monday, September 24, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 24, 2018ABANDONMENT - NO USE STATEMENT FILED
Saturday, February 24, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 23, 2018EXTENSION 5 GRANTED
Thursday, February 15, 2018EXTENSION 5 FILED
Thursday, February 15, 2018TEAS EXTENSION RECEIVED
Friday, August 18, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 16, 2017EXTENSION 4 GRANTED
Wednesday, August 16, 2017EXTENSION 4 FILED
Wednesday, August 16, 2017TEAS EXTENSION RECEIVED
Wednesday, March 1, 2017ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, March 1, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 28, 2017EXTENSION 3 GRANTED
Friday, February 10, 2017EXTENSION 3 FILED
Friday, February 10, 2017TEAS EXTENSION RECEIVED
Thursday, February 9, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 9, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 16, 2016ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, September 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 14, 2016EXTENSION 2 GRANTED
Tuesday, August 16, 2016EXTENSION 2 FILED
Friday, September 9, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 16, 2016TEAS EXTENSION RECEIVED
Saturday, January 30, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 28, 2016EXTENSION 1 GRANTED
Thursday, January 28, 2016EXTENSION 1 FILED
Thursday, January 28, 2016TEAS EXTENSION RECEIVED
Tuesday, August 18, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 23, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 23, 2015PUBLISHED FOR OPPOSITION
Wednesday, June 3, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 19, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, May 18, 2015ASSIGNED TO LIE
Thursday, April 23, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 23, 2015EXAMINER'S AMENDMENT ENTERED
Thursday, April 23, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, April 23, 2015EXAMINERS AMENDMENT E-MAILED
Thursday, April 23, 2015EXAMINERS AMENDMENT -WRITTEN
Thursday, April 23, 2015ASSIGNED TO EXAMINER
Saturday, January 31, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 23, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

bydenaf treating preparations pharmaceutical disorders disease related mitochondrial nash nafld fibrotic